Search

Your search keyword '"Bizien, Lucy"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Bizien, Lucy" Remove constraint Author: "Bizien, Lucy"
122 results on '"Bizien, Lucy"'

Search Results

1. SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.

2. Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals.

3. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

4. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

5. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

6. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

7. Neutralizing IFN-[gamma] autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals

8. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia

9. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

10. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

11. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child

12. Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study

13. Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study

14. A sensitive assay for measuring whole-blood responses to type I IFNs.

15. Microglial TNFa controls daily changes in synaptic GABAARs and sleep slow waves.

16. Author Reply to Peer Reviews of Microglial TNFα controls synaptic GABAARs, sleep slow waves and memory consolidation

17. Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients

18. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

19. Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-kB pathway

20. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

21. Additional file 1 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

22. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising IFN-α

23. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

24. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

25. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

26. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

27. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

28. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

29. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

30. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

31. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes

32. Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency

33. Microglial TNFα controls synaptic GABAARs, sleep slow waves and memory consolidation

34. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

35. Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths

36. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases

37. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

38. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

39. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine

40. Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease

41. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

42. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

43. Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency

44. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

45. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

46. Microglial TNFα controls daily changes in synaptic GABAARs and sleep slow waves.

47. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.

48. Correction: Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency.

49. Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

50. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Catalog

Books, media, physical & digital resources